IRF2BPL
Probable E3 ubiquitin-protein ligase IRF2BPL
Also known as: C14orf4, EAP1, I2BPL_HUMAN, KIAA1865
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H1B7
- Gene
- IRF2BPL
- Ensembl
- ENSG00000119669
- Chromosome
- 14
- Canonical length
- 796 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
This gene encodes a transcription factor that may play a role in regulating female reproductive function. [provided by RefSeq, Jun 2012]
Canonical amino-acid sequenceUniProt
796 residues, UniProt reviewed canonical sequence.
>Q9H1B7|IRF2BPL
1 MSAAQVSSSR RQSCYLCDLP RMPWAMIWDF SEPVCRGCVN YEGADRIEFV IETARQLKRA
61 HGCFQDGRSP GPPPPVGVKT VALSAKEAAA AAAAAAAAAA AAQQQQQQQQ QQQQQQQQQQ
121 QQQQQQQLNH VDGSSKPAVL AAPSGLERYG LSAAAAAAAA AAAAVEQRSR FEYPPPPVSL
181 GSSSHTARLP NGLGGPNGFP KPTPEEGPPE LNRQSPNSSS AAASVASRRG THGGLVTGLP
241 NPGGGGGPQL TVPPNLLPQT LLNGPASAAV LPPPPPHALG SRGPPTPAPP GAPGGPACLG
301 GTPGVSATSS SASSSTSSSV AEVGVGAGGK RPGSVSSTDQ ERELKEKQRN AEALAELSES
361 LRNRAEEWAS KPKMVRDTLL TLAGCTPYEV RFKKDHSLLG RVFAFDAVSK PGMDYELKLF
421 IEYPTGSGNV YSSASGVAKQ MYQDCMKDFG RGLSSGFKYL EYEKKHGSGD WRLLGDLLPE
481 AVRFFKEGVP GADMLPQPYL DASCPMLPTA LVSLSRAPSA PPGTGALPPA APSGRGAAAS
541 LRKRKASPEP PDSAEGALKL GEEQQRQQWM ANQSEALKLT MSAGGFAAPG HAAGGPPPPP
601 PPLGPHSNRT TPPESAPQNG PSPMAALMSV ADTLGTAHSP KDGSSVHSTT ASARRNSSSP
661 VSPASVPGQR RLASRNGDLN LQVAPPPPSA HPGMDQVHPQ NIPDSPMANS GPLCCTICHE
721 RLEDTHFVQC PSVPSHKFCF PCSRESIKAQ GATGEVYCPS GEKCPLVGSN VPWAFMQGEI
781 ATILAGDVKV KKERDPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against IRF2BPL can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.56
- Highest tissue expression
- 31 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 31 nTPM
- ovary: 30 nTPM
- colon: 30 nTPM
- breast: 27 nTPM
- fallopian tube: 25 nTPM
- adipose tissue: 25 nTPM
Single-cell type
- neutrophils: 172 nCPM
- undifferentiated spermatogonia: 107 nCPM
- smooth muscle cells: 80 nCPM
- extravillous trophoblasts: 75 nCPM
- basal keratinocytes: 73 nCPM
- vascular smooth muscle cells: 72 nCPM
Immune cell
- plasmacytoid DC: 11 nTPM
- neutrophil: 9 nTPM
- NK-cell: 5.9 nTPM
- gdT-cell: 2.8 nTPM
- MAIT T-cell: 2.7 nTPM
- memory CD8 T-cell: 2.6 nTPM
Brain region
- hypothalamus: 65 nTPM
- medulla oblongata: 53 nTPM
- midbrain: 53 nTPM
- hippocampal formation: 50 nTPM
- basal ganglia: 49 nTPM
- cerebellum: 48 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about IRF2BPL.
Disease | AllUniProt
Conditions IRF2BPL is implicated in, by any mechanism.
- Neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures (NEDAMSS) MIM:618088
Disease | GeneticClinVar
98 pathogenic / likely-pathogenic of 574 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures
- Inborn genetic diseases
- IRF2BPL-related disorder
- Neurodevelopmental disorder
- Global developmental delay
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.41
- gnomAD pLI
- 0.84
- gnomAD missense Z
- 0.73
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- development of secondary female sexual characteristics
- negative regulation of transcription by RNA polymerase II
- nervous system development
- positive regulation of transcription by RNA polymerase II
- protein ubiquitination
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Interferon regulatory factor 2-binding protein 1/2-like, zinc finger
- Interferon regulatory factor 2-binding protein 1/2, C3HC4-type RING finger superfamily
- Interferon regulatory factor 2-binding protein 1/2-like, C3HC4 zinc finger domain
- IRF-2BP1/2-like, middle domain
- Interferon regulatory factor 2-binding protein zinc finger
- IRF-2BP1/2 C3HC4 zinc finger domain
- IRF-2BP1/2 middle domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of IRF2BPL in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IRF2BPL as an antibody target. Whether an autoantibody or antibody against IRF2BPL could matter depends on whether native IRF2BPL is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IRF2BPL is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label IRF2BPL as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...